scholarly journals Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: A children's oncology group study

2013 ◽  
Vol 61 (5) ◽  
pp. 833-839 ◽  
Author(s):  
Rochelle Bagatell ◽  
Robin Norris ◽  
Ashish M. Ingle ◽  
Charlotte Ahern ◽  
Stephan Voss ◽  
...  
Keyword(s):  
Young Adults ◽  
Solid Tumors ◽  
Phase 1 ◽  
Adolescents And Young Adults ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Phase 1 Trial

Phase 1 evaluation of EZN-2208, a polyethylene glycol conjugate of SN38, in children adolescents and young adults with relapsed or refractory solid tumors

2014 ◽  
Vol 61 (10) ◽  
pp. 1792-1797 ◽  
Author(s):  
Robin E. Norris ◽  
Suzanne Shusterman ◽  
Lia Gore ◽  
Jodi A. Muscal ◽  
Margaret E. Macy ◽  
...  
Keyword(s):  
Young Adults ◽  
Polyethylene Glycol ◽  
Solid Tumors ◽  
Phase 1 ◽  
Adolescents And Young Adults

Phase 1 Study of Paclitaxel Administered Twice Weekly to Children With Refractory Solid Tumors: A Pediatric Oncology Group Study

2003 ◽  
Vol 25 (7) ◽  
pp. 539-542 ◽  
Author(s):  
Robert J. Hayashi ◽  
Susan Blaney ◽  
Jim Sullivan ◽  
Steve Weitman ◽  
Teresa Vietti ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Pediatric Oncology ◽  
Phase 1 ◽  
Oncology Group ◽  
Phase 1 Study ◽  
Oncology Group Study ◽  
Pediatric Oncology Group

scholarly journals A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111)

2017 ◽  
Vol 64 (11) ◽  
pp. e26565 ◽  
Author(s):  
James I. Geller ◽  
John P. Perentesis ◽  
Xiaowei Liu ◽  
Charles G. Minard ◽  
Rachel A. Kudgus ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Phase 1 ◽  
Study Phase ◽  
Oncology Group ◽  
Phase 1 Study ◽  
Oncology Group Study ◽  
Met Inhibitor

scholarly journals Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors

2015 ◽  
Vol 62 (4) ◽  
pp. 603-610 ◽  
Author(s):  
Srivandana Akshintala ◽  
Leigh Marcus ◽  
Katherine E. Warren ◽  
Robert F. Murphy ◽  
Tristan M. Sissung ◽  
...  
Keyword(s):  
Young Adults ◽  
Brain Tumors ◽  
Solid Tumors ◽  
Pharmacokinetic Study ◽  
Phase 1 ◽  
Phase 1 Trial ◽  
Children And Young Adults

Phase 1 study of entrectinib (RXDX-101), a TRK, ROS1, and ALK inhibitor, in children, adolescents, and young adults with recurrent or refractory solid tumors.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 10536-10536 ◽  
Author(s):  
Ami Vijay Desai ◽  
Garrett M. Brodeur ◽  
Jennifer Foster ◽  
Stacey L. Berg ◽  
Ellen M. Basu ◽  
...  
Keyword(s):  
Young Adults ◽  
Solid Tumors ◽  
Phase 1 ◽  
Adolescents And Young Adults ◽  
Phase 1 Study ◽  
Alk Inhibitor

scholarly journals Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213)

2018 ◽  
Vol 65 (5) ◽  
pp. e26944 ◽  
Author(s):  
Robin E. Norris ◽  
Elizabeth Fox ◽  
Joel M. Reid ◽  
Andrew Ralya ◽  
Xiaowei W. Liu ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Phase 1 ◽  
Oncology Group ◽  
Phase 1 Trial

A phase 1 study of the c-Met inhibitor tivantinib (ARQ 197, IND#112603) in children with relapsed or refractory solid tumors: A Children’s Oncology Group study.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 2627-2627 ◽  
Author(s):  
James I. Geller ◽  
John Peter Perentesis ◽  
Charlotte H. Ahern ◽  
Rachel A. Kudgus ◽  
Elizabeth Fox ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Phase 1 ◽  
Oncology Group ◽  
Phase 1 Study ◽  
Oncology Group Study ◽  
Arq 197 ◽  
Met Inhibitor
Sign in / Sign up

Export Citation Format

Share Document